Patients Rethinking prescription drug affordability, with Vinay Patel Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Patients The NHS, system burden, and a transformation prescription, w... Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.
Patients FH25: On patient access and equity, with Roberta Sarno In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.
Patients FH25: Exploring the intersection of patients, HCPs, and tech... In a new FH25 podcast, Denise Silber, founder of Basil Strategies and Doctors 2.0, discusses the intersection of HCPs, patients, and technology.
News J&J bets on Isomorphic for AI-powered drug hunt Isomorphic Labs has added Johnson & Johnson to the roster of pharma companies tapping into its AI-based drug discovery engine.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
